TY - JOUR
T1 - Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects
T2 - a systematic review and meta-analysis
AU - Sardanelli, Francesco
AU - Schiaffino, Simone
AU - Zanardo, Moreno
AU - Secchi, Francesco
AU - Cannaò, Paola Maria
AU - Ambrogi, Federico
AU - Di Leo, Giovanni
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Objectives: To estimate the MRI-derived myocardial extracellular volume (ECV) in healthy subjects together with reference normality interval. Methods: The study was registered on PROSPERO and reported according to PRISMA. In October 2017, a systematic search (MEDLINE/EMBASE) was performed for articles reporting MRI-derived ECV in healthy subjects. The pooled ECV (pECV) with 95% confidence interval (CI) was calculated using the random-effect model; the normality interval was calculated as pECV ± 2 root mean square of all study standard deviations. The Newcastle-Ottawa scale was used for assessing study quality, subgroup/meta-regression analyses for technical/biological covariates, and Egger test for publication bias risk. Results: Of 282 articles, 56 were analyzed totaling 1851 subjects with age 16–68 years, body mass index 23–28 kg/m2, and left ventricular ejection fraction 58–74%. Contrast dose varied from 0.075 to 0.200 mmol/kg. Heterogeneity was high (I2 = 92%). The pECV was 25.6% (95% CI 25.2–26.0%) with a normality interval of 19.6–31.6%. pECV was slightly increasing with age (β = 0.03%, p = 0.038) and slightly decreasing with the percentage of males (β = − 0.02%, p = 0.053). Sequence type significantly (p = 0.003) impacted on pECV: the normal interval was 19.9–31.9% for MOLLI and 20.3–33.5% for ShMOLLI. Contrast type/dose, time of acquisition, and magnetic field strength did not significantly impact pECV (p > 0.093). Quality was moderate or high in 48/56 studies (86%). No risk of publication bias (p = 0.728). Conclusions: Myocardial pECV in healthy subjects was 25.6%, increasing by 0.03% for each year of age. The ECV normality interval was 19.9–31.9% for MOLLI and 20.3–33.5% for ShMOLLI. Key Points: • The pooled estimate of normal MRI-derived ECV based on 1851 subjects was 25.6%, slightly increasing with age and slightly decreasing with the percentage of males. • MRI-derived ECV was independent of contrast type/dose and field strength but dependent on the imaging sequence. • The modeled normality reference interval of MRI-derived ECV was 19.9–31.9% for the MOLLI sequence and 20.3–33.5% for the ShMOLLI sequence.
AB - Objectives: To estimate the MRI-derived myocardial extracellular volume (ECV) in healthy subjects together with reference normality interval. Methods: The study was registered on PROSPERO and reported according to PRISMA. In October 2017, a systematic search (MEDLINE/EMBASE) was performed for articles reporting MRI-derived ECV in healthy subjects. The pooled ECV (pECV) with 95% confidence interval (CI) was calculated using the random-effect model; the normality interval was calculated as pECV ± 2 root mean square of all study standard deviations. The Newcastle-Ottawa scale was used for assessing study quality, subgroup/meta-regression analyses for technical/biological covariates, and Egger test for publication bias risk. Results: Of 282 articles, 56 were analyzed totaling 1851 subjects with age 16–68 years, body mass index 23–28 kg/m2, and left ventricular ejection fraction 58–74%. Contrast dose varied from 0.075 to 0.200 mmol/kg. Heterogeneity was high (I2 = 92%). The pECV was 25.6% (95% CI 25.2–26.0%) with a normality interval of 19.6–31.6%. pECV was slightly increasing with age (β = 0.03%, p = 0.038) and slightly decreasing with the percentage of males (β = − 0.02%, p = 0.053). Sequence type significantly (p = 0.003) impacted on pECV: the normal interval was 19.9–31.9% for MOLLI and 20.3–33.5% for ShMOLLI. Contrast type/dose, time of acquisition, and magnetic field strength did not significantly impact pECV (p > 0.093). Quality was moderate or high in 48/56 studies (86%). No risk of publication bias (p = 0.728). Conclusions: Myocardial pECV in healthy subjects was 25.6%, increasing by 0.03% for each year of age. The ECV normality interval was 19.9–31.9% for MOLLI and 20.3–33.5% for ShMOLLI. Key Points: • The pooled estimate of normal MRI-derived ECV based on 1851 subjects was 25.6%, slightly increasing with age and slightly decreasing with the percentage of males. • MRI-derived ECV was independent of contrast type/dose and field strength but dependent on the imaging sequence. • The modeled normality reference interval of MRI-derived ECV was 19.9–31.9% for the MOLLI sequence and 20.3–33.5% for the ShMOLLI sequence.
KW - Biomarkers
KW - Cardiomyopathies
KW - Fibrosis
KW - Magnetic resonance imaging
KW - Meta-analysis
UR - http://www.scopus.com/inward/record.url?scp=85065404853&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065404853&partnerID=8YFLogxK
U2 - 10.1007/s00330-019-06185-w
DO - 10.1007/s00330-019-06185-w
M3 - Review article
C2 - 31049734
AN - SCOPUS:85065404853
SN - 0938-7994
VL - 29
SP - 6620
EP - 6633
JO - European Radiology
JF - European Radiology
IS - 12
ER -